UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
NCC builds ‘alternative splicing’ database for cancer biomarkers
Professor Park Charny The National Cancer Center (NCC) said Tuesday that ...
by Lee Han-soo
|
2017-12-19 10:58
라인
Daehwa Pharma launches clinical trial for breast cancer treatment
Daehwa Pharmaceuticals said that it has launched phase 2/3 clinical trials ...
by Lee Han-soo
|
2017-12-18 16:59
라인
Green Cross unveils non-clinical trial data for hemophilia A treatment
Green Cross said Monday that it has presented non-clinical trial data for M...
by Lee Han-soo
|
2017-12-18 15:12
라인
KPBMA lays out plans for 2018
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) l...
by Lee Han-soo
|
2017-12-18 13:59
라인
Samsung Bioepis, Daewoong sign exclusive supply contract for Samfenet
Samsung Bioepis and Daewoong Pharmaceuticals have signed an exclusive suppl...
by Lee Han-soo
|
2017-12-18 10:59
라인
Corestem’s NeuroNata-R marks increase in foreign patients
The number of foreign patients visiting Korea to use Corestem’s NeuroNata-R...
by Lee Han-soo
|
2017-12-15 16:22
라인
Korea, China agree to cooperate on healthcare
The Ministry of Health and Welfare said Thursday that it has signed a revis...
by Lee Han-soo
|
2017-12-15 14:24
라인
FDA approves Pfizer’s Remicade biosimilar
Pfizer said Wednesday that it received U.S. Food and Drug Administration’s ...
by Lee Han-soo
|
2017-12-14 17:16
라인
Hironic wins ministry certification for Q-Fit
Hironic, a Korean medical device company, said Thursday that it has receive...
by Lee Han-soo
|
2017-12-14 15:14
라인
Samsung BioLogics’ 2nd factory gets European approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo
|
2017-12-14 10:52
라인
Syntekabio, CJ Healthcare agree to develop new drugs using AI
Syntekabio and CJ Healthcare have signed an agreement to co-develop a new i...
by Lee Han-soo
|
2017-12-13 17:17
라인
FDA approves treatment for eosinophilic granulomatosis with polyangiitis
The U.S. Food and Drug Administration (FDA) Wednesday approved GlaxoSmithKl...
by Lee Han-soo
|
2017-12-13 14:35
라인
Misdiagnosis of Segawa syndrome sparks public debate
A controversy arose over a 20-year-old woman, who had been bound – en...
by Lee Han-soo
|
2017-12-13 11:26
라인
Bio-industry output sees steady growth
The Ministry of Trade, Industry and Energy (MOTIE) said Tuesday that the do...
by Lee Han-soo
|
2017-12-12 15:52
라인
Huons wins patent for oral medication of clarithromycin
Huons, a subsidiary of Huons Global, said Tuesday that it has acquired a pa...
by Lee Han-soo
|
2017-12-12 11:41
라인
JW Pharma unveils trial result for target anticancer treatment
JW Pharmaceuticals said Monday that it has presented phase 1a/1b clinical t...
by Lee Han-soo
|
2017-12-11 16:55
라인
KIST finds nanomaterial that can break down cancer cell barrier
Researchers at Korea Institute of Science and Technology (KIST) have develo...
by Lee Han-soo
|
2017-12-11 15:11
라인
SNUBH diagnoses ovarian cancer with blood test
Researchers at Seoul National University Bundang Hospital (SNUBH) have deve...
by Lee Han-soo
|
2017-12-11 12:04
라인
Toolgen wins German utility model for gene editing tool
Toolgen said Friday that it has completed the registration of two German ut...
by Lee Han-soo
|
2017-12-08 16:56
라인
Constitutional Court upholds ban on cord blood sales
The Constitutional Court ruled on Friday that the clause in the cord blood ...
by Lee Han-soo
|
2017-12-08 15:16
-
이전
111
112
113
114
115
116
117
118
119
120
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top